Despite the wide variety of anti-tuberculosis drugs, tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), remains a public health challenge today, claiming millions of lives and new cases every year. This success of MTB is in part due to the discontinuity of its life cycle in the host system, owing to its ability to enter and exit from different states in response to the antimycobacterial host defense mechanisms, enabling it to infect, grow, persist and survive in human macrophages. Enhanced service provision of the existing antibiotics in recent years through Direct Observed Treatment as implemented by the World Health Organization (WHO) is of immense value in controlling the disease.
OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the dramatic effort of editorial board members. Journal of Bacteriology & Parasitology publishes original research articles, novel, and scientifically sound findings dealing with Bacteria and Parasites of Medical relevance to human or veterinary health, as well as those with application in Environmental or Food Sciences related to microbiology.
Last date updated on June, 2014